AVTR · Avantor, Inc. · Executive Compensation

$15.03 -0.02 (-0.13%)

S&P 400 member Russell 1000 member Rebalance outlook locked

Market Cap

$10.37B

682.76M

Volume · Oct 1 10.57M Avg daily vol (3M) 9.4M

Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.

Fiscal 2025

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Michael Stubblefield	Former Chief Executive Officer	$1,140,000	—	$8,125,784	$2,749,997	$1,022,795	$39,355	$13,077,931
Brent Jones	CFO	$653,269	—	$4,823,755	$749,999	$272,288	$39,355	$6,538,667
R. Brent Jones	Executive Vice President and Chief Financial Officer	$653,269	—	$4,823,755	$749,999	$272,288	$39,355	$6,538,667
Corey Walker	President Laboratory Solutions	$700,000	—	$4,173,757	$749,999	$322,755	$41,305	$5,987,816
Emmanuel Ligner	Director, President and Chief Executive Officer	$379,297	—	$2,499,990	$2,499,998	$330,038	$186,301	$5,895,624
Benoit Gourdier	Executive Vice President Bioscience Production	$550,000	—	$3,804,417	$624,999	$215,921	$30,082	$5,225,419
Claudius Sokenu	Executive Vice President, Chief Legal and Compliance Officer	$550,000	—	$2,576,284	$375,000	$208,317	$40,312	$3,749,913

Fiscal 2024

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Michael Stubblefield	Former Chief Executive Officer	$1,126,846	—	$8,651,135	$2,625,038	$2,085,069	$37,550	$14,525,638
R. Brent Jones	Executive Vice President and Chief Financial Officer	$611,519	—	$2,059,777	$625,020	$554,220	$35,915	$3,886,451
Brent Jones	CFO	$611,519	—	$2,059,777	$625,020	$554,220	$35,915	$3,886,451
Benoit Gourdier	Executive Vice President Bioscience Production	$516,057	—	$2,059,777	$625,020	$512,210	$20,000	$3,733,064
Claudius Sokenu	Executive Vice President, Chief Legal and Compliance Officer	$543,654	—	$1,400,628	$425,033	$431,739	$31,804	$2,832,857

Fiscal 2023

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Michael Stubblefield	Director, President and Chief Executive Officer	$1,140,000	—	$8,529,219	$2,437,053	$188,100	$36,500	$12,338,767
Brent Jones	CFO	$221,154	$200,000	$2,817,998	$2,561,102	$18,526	$22,015	$5,840,795
R. Brent Jones	Executive Vice President and Chief Financial Officer	$221,154	$200,000	$2,817,998	$2,561,102	$18,526	$22,015	$5,840,795
Randy Stone	Executive Vice President	$415,385	—	$2,105,342	$1,999,997	$34,192	$33,200	$4,588,116
Frederic Vanderhaegen	Executive Vice President Europe	$618,212	—	$1,749,559	$499,925	$52,761	$122,895	$3,043,353
Gerard Brophy	Former Executive Vice President,	$575,000	—	$1,749,559	$499,925	$46,000	$29,231	$2,907,627
Thomas Szlosek	Former Executive Vice President and Chief Financial Officer	$369,231	—	$1,924,529	$549,903	—	$33,200	$2,882,892
James Bramwell	Executive Vice President, Americas	$497,981	—	$1,749,559	$499,925	$39,384	$33,650	$2,840,235

Fiscal 2022

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Michael Stubblefield	Director, President and Chief Executive Officer	$1,127,308	—	$7,371,470	$2,313,486	—	$19,502	$10,831,766
Thomas Szlosek	Former Executive Vice President and Chief Financial Officer	$600,000	—	$1,753,183	$550,255	—	$16,586	$2,923,808
Frederic Vanderhaegen	Executive Vice President Europe	$577,652	—	$1,593,803	$500,229	—	$88,467	$2,760,151
Gerard Brophy	Former Executive Vice President,	$563,462	—	$1,593,803	$500,229	—	$16,006	$2,676,620
Sheri Lewis	Executive Vice President, Global Operations & Supply Chain	$475,000	—	$1,036,025	$325,101	—	$15,618	$1,851,744

Fiscal 2021

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Michael Stubblefield	Director, President and Chief Executive Officer	$1,085,000	—	$6,633,149	$2,000,000	$3,523,212	$14,210	$13,260,913
Thomas Szlosek	Former Executive Vice President and Chief Financial Officer	$600,000	—	$1,492,479	$449,998	$1,771,200	$16,674	$4,335,943
Frederic Vanderhaegen	Executive Vice President Europe	$579,674	—	$1,492,479	$449,998	$962,718	$80,238	$3,565,108
Gerard Brophy	Executive Vice President	$513,462	—	$1,492,479	$449,998	$862,406	$15,018	$3,338,920
Biopharma Production	—	$513,462	—	$1,492,479	$449,998	$862,406	$15,018	$3,338,920
Sheri Lewis	Executive Vice President, Global Operations & Supply Chain	$469,519	$250,000	$1,243,687	$375,000	$560,880	$14,887	$2,913,973

Fiscal 2020

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Michael Stubblefield	Director, President and Chief Executive Officer	$1,085,000	—	$4,813,959	$2,499,998	$2,372,081	$479,752	$11,257,062
Thomas Szlosek	Executive Vice President and Chief Financial Officer	$600,000	—	$2,405,359	$1,849,997	$1,371,275	$11,400	$6,243,778
Frederic Vanderhaegen	Executive Vice President Europe	$495,457	—	$1,962,814	$1,500,000	$615,451	$64,289	$4,638,011
Biopharma Production	—	$474,693	—	$1,834,438	$1,433,330	$519,234	$11,400	$4,278,996
Gerard Brophy	Executive Vice President	$474,693	—	$1,834,438	$1,433,330	$519,234	$11,400	$4,278,996
Michael Wondrasch	Executive Vice President,Chief Information Officer	$399,731	—	$1,327,669	$1,050,004	$397,500	$11,400	$3,192,367

Fiscal 2019

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Michael Stubblefield	Director, President and Chief Executive Officer	$984,308	$130,000	$14,000,000	—	$1,282,296	$593,526	$16,995,265
Ashish Kulkarni	Executive Vice President and Chief Technology Officer	$400,000	$737,000	$1,799,994	—	—	$2,126,062	$5,068,233
Thomas Szlosek	Executive Vice President and Chief FinancialOfficer	$600,000	—	$2,599,996	—	$765,000	$11,200	$3,977,065
Devashish Ohri	Executive Vice President, IMEA	$366,807	—	$2,200,002	—	$92,087	$633,423	$3,292,319

Executive changes

Person	Role	Change	Effective	Filed
Todd Garner	Executive Vice President and Chief Financial Officer	Appointed	2026-09-21	2026-09-21
Todd Garner	Executive Vice President and Chief Financial Officer	Appointed	2026-09-21	2026-09-21
Ludovic Brellier	Executive Vice President, Bioscience and Medtech Products and Chief Transformation Officer	Appointed	2026-05-01	2026-04-23
R. Brent Jones	Executive Vice President and Chief Financial Officer	Resigned	—	2026-04-01
Jonathan Peacock	director	Resigned	2025-12-31	2025-12-18
Simon Dingemans	director	Appointed	2026-01-02	2025-12-18
Sanjeev Mehra	director	Appointed	2025-12-04	2025-12-04
Mary Blenn	Executive Vice President and Chief Operating Officer	Appointed	2025-11-10	2025-11-10
Gregory L. Summe	chairman	Appointed	2026-01-01	2025-10-14
Gregory Lucier	director	Appointed	2025-10-03	2025-10-03
Emmanuel Ligner	director	Appointed	2025-08-18	2025-08-13
Emmanuel Ligner	President and Chief Executive Officer	Appointed	2025-08-18	2025-07-21
Dame Louise Makin DBE	director	Appointed	2024-11-04	2024-11-06
Corey Walker	President, Laboratory Solutions	Appointed	2024-06-21	2024-06-21
Randy Stone	Executive Vice President, Laboratory Solutions	Terminated	2024-06-30	2024-06-21
Dr. Gerard Brophy	Executive Vice President, Biopharma Production	Retired	2024-02-29	2023-09-26
Dr. Gerard Brophy	Executive Vice President, Biopharma Production	Resigned	2023-10-02	2023-09-26
R. Brent Jones	Executive Vice President and Chief Financial Officer	Appointed	2023-08-07	2023-07-13
Thomas A. Szlosek	Executive Vice President and Chief Financial Officer	Resigned	2023-08-02	2023-05-15
Matt Holt	Board of Directors	Retired	2022-11-16	2022-11-18

Key facts CIK 1722482 CUSIP 05352A100 13F (30d) 10 filings 9 filers Visit website Investor relations